ATE419356T1 - Chemoattraktion-auslösender faktor aus lymphozyten und dessen verwendung - Google Patents
Chemoattraktion-auslösender faktor aus lymphozyten und dessen verwendungInfo
- Publication number
- ATE419356T1 ATE419356T1 AT01201544T AT01201544T ATE419356T1 AT E419356 T1 ATE419356 T1 AT E419356T1 AT 01201544 T AT01201544 T AT 01201544T AT 01201544 T AT01201544 T AT 01201544T AT E419356 T1 ATE419356 T1 AT E419356T1
- Authority
- AT
- Austria
- Prior art keywords
- chemoattraction
- lymphocytes
- triggering factor
- lcf
- triggering
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5446—IL-16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6894993A | 1993-05-21 | 1993-05-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE419356T1 true ATE419356T1 (de) | 2009-01-15 |
Family
ID=22085751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01201544T ATE419356T1 (de) | 1993-05-21 | 1994-05-16 | Chemoattraktion-auslösender faktor aus lymphozyten und dessen verwendung |
Country Status (7)
Country | Link |
---|---|
US (2) | US5807712A (de) |
EP (3) | EP0700439A1 (de) |
JP (3) | JP4278710B2 (de) |
AT (1) | ATE419356T1 (de) |
DE (1) | DE69435177D1 (de) |
ES (1) | ES2320090T3 (de) |
WO (1) | WO1994028134A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5807549A (en) * | 1993-05-21 | 1998-09-15 | Research Corporation Technologies, Inc. | Lymphocyte chemoattractant factor and uses thereof |
EP0700439A1 (de) * | 1993-05-21 | 1996-03-13 | Trustees Of Boston University | Chemoattraktion auslösender faktor aus lymphozyten und seine verwendungsmöglichkeiten |
DE19513152A1 (de) | 1995-04-07 | 1996-10-10 | Bundesrep Deutschland | Verwendung eines "Immundefizienzvirus-supprimierenden Lymphokins (ISL)" zur Hemmung der Virusvermehrung, insbesondere von Retroviren |
DE19547933A1 (de) * | 1995-12-22 | 1997-06-26 | Boehringer Mannheim Gmbh | Multimere Formen von IL-16, Verfahren zu ihrer Herstellung und Verwendung |
EP0870030A1 (de) * | 1995-12-22 | 1998-10-14 | Bundesrepublik Deutschland vertreten durch den Bundesminister für Gesundheit | Polypeptide mit il-16-aktivität, verfahren zu ihrer herstellung und verwendung |
DE19614099A1 (de) * | 1996-04-10 | 1997-10-16 | Bundesrep Deutschland | Genomische Nukleinsäuren, die für Polypeptide mit IL-16-Aktivität codieren, Verfahren zu ihrer Herstellung und Verwendung |
DE19780377D2 (de) * | 1996-04-30 | 1999-08-05 | Bundesrep Deutschland | Prozessierte Polypeptide mit IL-16-Aktivität, Verfahren zu ihrer Herstellung und Verwendung |
US6444202B1 (en) * | 1996-11-25 | 2002-09-03 | Bundesrepublic Deutschland, Vertreten Durch Den Bundesminister Fur Gesundheit | Processed polypeptides with IL-16 activity, processes for their production and their use |
BR9907216A (pt) * | 1998-01-24 | 2000-10-24 | Bundesrep Deutschland | Mutantes de il-16, processos para sua produção e utilização dos mesmos |
WO1999048514A1 (en) * | 1998-03-25 | 1999-09-30 | Mayo Foundation For Medical Education And Research | Methods and materials for treating inflammatory diseases |
US6699466B1 (en) | 1999-08-05 | 2004-03-02 | Research Corporation Technologies, Inc. | IL-16 antagonist peptides and DNA encoding the peptides |
WO2001010891A2 (en) * | 1999-08-05 | 2001-02-15 | Research Corporation Technologies, Inc. | Il-16 antagonists |
EP2076777A4 (de) * | 2006-09-28 | 2009-12-30 | Centocor Ortho Biotech Inc | Verfahren zur erkennung von il-16-aktivität und modulation von il-16-aktivität auf basis der proxy-konzentrationen von phosphoryliertem stat6 |
US7754207B2 (en) * | 2006-10-27 | 2010-07-13 | Centocor Ortho Biotech Inc. | Methods of treating pulmonary fibrosis |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3958661A (en) * | 1972-09-06 | 1976-05-25 | Atlantic Richfield Company | Method and apparatus for generating seismic waves |
US3889710A (en) * | 1972-11-07 | 1975-06-17 | Julien H Brost | Check valve with elastomeric valve element |
JPS59205026A (ja) * | 1983-05-02 | 1984-11-20 | Yaskawa Electric Mfg Co Ltd | 磁気軸受装置の制御方法 |
US4745051A (en) * | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
US4863727A (en) * | 1986-04-09 | 1989-09-05 | Cetus Corporation | Combination therapy using interleukin-2 and tumor necrosis factor |
US5807549A (en) * | 1993-05-21 | 1998-09-15 | Research Corporation Technologies, Inc. | Lymphocyte chemoattractant factor and uses thereof |
EP0700439A1 (de) * | 1993-05-21 | 1996-03-13 | Trustees Of Boston University | Chemoattraktion auslösender faktor aus lymphozyten und seine verwendungsmöglichkeiten |
-
1994
- 1994-05-16 EP EP94917399A patent/EP0700439A1/de not_active Withdrawn
- 1994-05-16 ES ES01201544T patent/ES2320090T3/es not_active Expired - Lifetime
- 1994-05-16 JP JP50073495A patent/JP4278710B2/ja not_active Expired - Fee Related
- 1994-05-16 DE DE69435177T patent/DE69435177D1/de not_active Expired - Lifetime
- 1994-05-16 EP EP01201543A patent/EP1155700A3/de not_active Ceased
- 1994-05-16 WO PCT/US1994/005442 patent/WO1994028134A1/en not_active Application Discontinuation
- 1994-05-16 EP EP01201544A patent/EP1203775B1/de not_active Expired - Lifetime
- 1994-05-16 AT AT01201544T patent/ATE419356T1/de active
- 1994-12-13 US US08/354,961 patent/US5807712A/en not_active Expired - Lifetime
-
1995
- 1995-12-29 US US08/581,103 patent/US6159463A/en not_active Expired - Fee Related
-
2006
- 2006-01-30 JP JP2006020169A patent/JP4279289B2/ja not_active Expired - Fee Related
-
2008
- 2008-12-25 JP JP2008330880A patent/JP4804529B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP4279289B2 (ja) | 2009-06-17 |
EP1203775A2 (de) | 2002-05-08 |
JP2006182783A (ja) | 2006-07-13 |
JP4278710B2 (ja) | 2009-06-17 |
US5807712A (en) | 1998-09-15 |
EP1155700A2 (de) | 2001-11-21 |
EP1203775B1 (de) | 2008-12-31 |
DE69435177D1 (de) | 2009-02-12 |
ES2320090T3 (es) | 2009-05-19 |
EP0700439A1 (de) | 1996-03-13 |
EP1203775A3 (de) | 2004-02-04 |
JP4804529B2 (ja) | 2011-11-02 |
JPH08510907A (ja) | 1996-11-19 |
EP1155700A3 (de) | 2002-01-02 |
JP2009149651A (ja) | 2009-07-09 |
US6159463A (en) | 2000-12-12 |
WO1994028134A1 (en) | 1994-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE419356T1 (de) | Chemoattraktion-auslösender faktor aus lymphozyten und dessen verwendung | |
DE69839437D1 (de) | Aus der embryonalhülle hergestellte transplantate, verfahren zur abtrennung, derkonservierung und verwendung solcher transplantate in der chirurgie | |
DE69736068D1 (de) | Faktor viii vom schwein und hybriden | |
DE69533564D1 (de) | Effektor-Proteine für Rapamycin | |
DE69931086D1 (de) | Vorrichtung zur Unterstützung der Handsortierung von Postartikeln | |
DK0994947T3 (da) | MU-1-medlem af cytokinreceptorfamilien | |
DK0795605T3 (da) | Denatureret lavdensitetslipoprotein-receptor | |
DE69432449D1 (de) | Verfahren zur Herstellung von hydrophoben Polypeptiden, Proteinen und Peptiden | |
DE68925275T2 (de) | Endotoxin-bindeprotein und dessen verwendung | |
DE69332798D1 (de) | Ikaros: ein regulatorisches gen bei der t-zell differenzierung | |
DE69016342T2 (de) | Zentrifuge zur Reinigung von Gasströmen und bei diesem Reiniger angewendetes Verfahren. | |
DE69425003T2 (de) | Verfahren zur Reinigung von Gasströmen | |
DE69426076T2 (de) | Gereinigte flt3 liganden von saeugentieren, agonisten und antagonisten davon | |
DE69433915D1 (de) | MDC-Proteine und dafür kodierende DNS | |
DE69328060T2 (de) | Angiotensin-II Typ-1 Rezeptor und dessen Herstellung | |
ATE165369T1 (de) | Antikoagulierende peptide | |
DE19736930B4 (de) | Vorrichtung zur Erhöhung der Tragfähigkeit von Brückenträgern | |
DE59702207D1 (de) | Verfahren zur eignungsprüfung von faktor viii-haltigen proteinfraktionen | |
ATE320266T1 (de) | Induktion von antigen-spezifischen t-zellen durch interferon | |
FI944166A0 (fi) | Laite lentokoneiden ja ajoneuvojen havaitsemiseksiLaite lentokoneiden ja ajoneuvojen havaitsemiseksi ja luokittelemiseksi, jotka edullisesti liikkuvat ja luokittelemiseksi, jotka edullisesti liikkuvat lähtö- ja laskeutumisradoilla tai kiitoradoilla lähtö- ja laskeutumisradoilla tai kiitoradoilla | |
DE29601518U1 (de) | Vorrichtung zur Vermittlung von Informationen über den Bewegungsablauf von Fahrzeugen | |
DE69233673D1 (de) | Protein S polypeptide und deren Verwendungen | |
DE69421665D1 (de) | Anomere Fluorribosylamine | |
DE69030293D1 (de) | Neue Peptide, deren Intermediate, Verfahren zu deren Herstellung, antiallergische Agenzien, Vasodilatoren und Immunoregulatoren | |
ES2059801T3 (es) | Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1203775 Country of ref document: EP |